Bempegaldesleukin (NKTR-214): a CD-122-biased IL-2 receptor...

  • Main
  • 2019 / 10
  • Bempegaldesleukin (NKTR-214): a CD-122-biased IL-2 receptor...

Bempegaldesleukin (NKTR-214): a CD-122-biased IL-2 receptor agonist for cancer immunotherapy

Doberstein, Stephen K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Expert Opinion on Biological Therapy
DOI:
10.1080/14712598.2019.1685489
Date:
October, 2019
File:
PDF, 923 KB
english, 2019
Conversion to is in progress
Conversion to is failed